Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of endothelial selectin ligands on human leukocytes following dive.
Glavas D, Markotic A, Valic Z, Kovacic N, Palada I, Martinic R, Breskovic T, Bakovic D, Brubakk AO, Dujic Z. Glavas D, et al. Among authors: kovacic n. Exp Biol Med (Maywood). 2008 Sep;233(9):1181-8. doi: 10.3181/0801-RM-28. Epub 2008 Jun 5. Exp Biol Med (Maywood). 2008. PMID: 18535169 Clinical Trial.
Fas receptor induces apoptosis of synovial bone and cartilage progenitor populations and promotes bone loss in antigen-induced arthritis.
Lazić Mosler E, Lukač N, Flegar D, Fadljević M, Radanović I, Cvija H, Kelava T, Ivčević S, Šućur A, Markotić A, Katavić V, Marušić A, Grčević D, Kovačić N. Lazić Mosler E, et al. Among authors: kovacic n. FASEB J. 2019 Mar;33(3):3330-3342. doi: 10.1096/fj.201801426R. Epub 2018 Nov 1. FASEB J. 2019. PMID: 30383451
These results suggest that Fas-induced apoptosis of early CD200(+) osteoprogenitor population represents potential mechanism underlying the impaired bone formation in arthritis, so their preservation may represent the bone-protective mechanism during arthritis.-Lazic Mosler, E., …
These results suggest that Fas-induced apoptosis of early CD200(+) osteoprogenitor population represents potential mechanism underlying the …
Presenting randomised trial reports.
Marusić A, Kovacić N, Petrak J. Marusić A, et al. Among authors: kovacic n. Lancet. 1998 Jan 3;351(9095):69. doi: 10.1016/S0140-6736(05)78049-1. Lancet. 1998. PMID: 9433451 No abstract available.
Role of B lymphocytes in new bone formation.
Marusic A, Grcevic D, Katavic V, Kovacic N, Lukic IK, Kalajzic I, Lorenzo JA. Marusic A, et al. Among authors: kovacic n. Lab Invest. 2000 Nov;80(11):1761-74. doi: 10.1038/labinvest.3780186. Lab Invest. 2000. PMID: 11092536 Free article.
122 results